| Price | 4.22 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | 2 - BUY |
| Open Price | $0.00 |
| Previous Close | $4.22 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $2.90 - $4.93 |
| Volume | 0 |
| Repligen Corporation develops new drugs based on naturally occurring peptides and proteins for autism, organ transplantation and immune system diseases. The company's lead therapeutic products are secretin for autism and CTLA4-Ig for organ transplantation and autoimmune diseases. The company manufactures and markets products based on Protein A for the purification of antibodies, and it owns commercial rights to products based on synthetic forms of secretin for the diagnosis of pancreatic function. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment